Format

Send to

Choose Destination
J Hepatol. 2012 Feb;56(2):486-7. doi: 10.1016/j.jhep.2011.07.033. Epub 2011 Sep 29.

Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma.

Author information

1
FundaciĆ³n Valle Del Lili, Cali, Colombia.
PMID:
21963517
DOI:
10.1016/j.jhep.2011.07.033
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center